Kenya Kanazawa

4.1k total citations
57 papers, 828 citations indexed

About

Kenya Kanazawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Kenya Kanazawa has authored 57 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 27 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Kenya Kanazawa's work include Lung Cancer Research Studies (17 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Diagnosis and Treatment (13 papers). Kenya Kanazawa is often cited by papers focused on Lung Cancer Research Studies (17 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Diagnosis and Treatment (13 papers). Kenya Kanazawa collaborates with scholars based in Japan, United States and United Kingdom. Kenya Kanazawa's co-authors include Mitsuru Munakata, Akio Wanaka, Noriaki Sukoh, Koichi Yamazaki, Takashi Ishida, Yoshihiro Tanno, Tetsuji Mori, Yutaka Honma, Michiko Tojo and Sachihiko Yokoya and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and FEBS Letters.

In The Last Decade

Kenya Kanazawa

53 papers receiving 815 citations

Peers

Kenya Kanazawa
Kenya Kanazawa
Citations per year, relative to Kenya Kanazawa Kenya Kanazawa (= 1×) peers Tatsuo Maeda

Countries citing papers authored by Kenya Kanazawa

Since Specialization
Citations

This map shows the geographic impact of Kenya Kanazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenya Kanazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenya Kanazawa more than expected).

Fields of papers citing papers by Kenya Kanazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenya Kanazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenya Kanazawa. The network helps show where Kenya Kanazawa may publish in the future.

Co-authorship network of co-authors of Kenya Kanazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kenya Kanazawa. A scholar is included among the top collaborators of Kenya Kanazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenya Kanazawa. Kenya Kanazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Yasuhito, Ryuichi Togawa, Natsumi Watanabe, et al.. (2024). Efficacy of combination antibiotic therapy including inhaled tobramycin on Burkholderia cepacia pneumonia in a non-cystic fibrosis patient. IDCases. 38. e02081–e02081.
2.
Sato, Yuki, Yoshinori Tanino, Takefumi Nikaido, et al.. (2022). Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer. BMC Pulmonary Medicine. 22(1). 191–191. 2 indexed citations
3.
Sato, Suguru, Junpei Saito, Atsuro Fukuhara, et al.. (2021). Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study. Journal of Asthma and Allergy. Volume 14. 325–334. 2 indexed citations
4.
Imai, Hisao, Hiroyuki Minemura, Yutaka Yamada, et al.. (2021). Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy. Oncology. 99(9). 562–570. 3 indexed citations
5.
Yamaguchi, Ou, Hisao Imai, Hiroyuki Minemura, et al.. (2020). Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 85(4). 761–771. 39 indexed citations
6.
Harada, Toshiyuki, Yosuke Kawashima, Yasuko Fujita, et al.. (2019). P1.01-08 Randomized Phase II Trial of CBDCA+nab-PTX vs CDDP+GEM in Patients with Chemo-Naïve Squamous Cell Lung Cancer: NJLCG1302. Journal of Thoracic Oncology. 14(10). S357–S357. 2 indexed citations
7.
Sato, Suguru, Takashi Umeda, Mami Rikimaru, et al.. (2018). A Case of Eosinophilic Granulomatosis with Polyangiitis Complicated with A IgG4 Related Disease Like Symptoms. SHILAP Revista de lepidopterología. 2018. 1–4. 4 indexed citations
9.
Imai, Hisao, Yutaka Yamada, Hiroyuki Minemura, et al.. (2018). Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis. Thoracic Cancer. 9(12). 1699–1706. 5 indexed citations
10.
Imai, Hisao, Tomohiro Tamura, Hiroyuki Minemura, et al.. (2017). A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients. Annals of Oncology. 28. x153–x153.
11.
Hirai, Kenichiro, Hiroshi Yokouchi, Hiroyuki Minemura, et al.. (2017). P3.02b-113 Clinical Course of NSCLC Patients with EGFR Mutation Undergoing Rebiopsy and Osimertinib Therapy. Journal of Thoracic Oncology. 12(1). S1261–S1262.
12.
Asano, Fumihiro, Takashi Ishida, Naofumi Shinagawa, et al.. (2017). Virtual bronchoscopic navigation without X-ray fluoroscopy to diagnose peripheral pulmonary lesions: a randomized trial. BMC Pulmonary Medicine. 17(1). 184–184. 33 indexed citations
13.
Imai, Hisao, Tomohide Sugiyama, Tomohiro Tamura, et al.. (2017). A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients. Cancer Chemotherapy and Pharmacology. 80(3). 615–622. 12 indexed citations
14.
Inoue, Takuya, Hironori Takagi, Yuzuru Watanabe, et al.. (2017). The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial. Trials. 18(1). 485–485. 18 indexed citations
15.
Minemura, Hiroyuki, Hiroshi Yokouchi, K. Azuma, et al.. (2015). A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer. BMC Research Notes. 8(1). 220–220. 6 indexed citations
16.
Tachihara, Motoko, Takashi Ishida, Naoko Fukuhara, et al.. (2014). Catheter Spray of Lidocaine : a Randomized Study of Topical Anesthesia for Flexible Bronchoscopy. 36(4). 359–363. 1 indexed citations
18.
Honma, Yutaka, Kenya Kanazawa, Tetsuji Mori, et al.. (1999). Identification of a novel gene, OASIS, which encodes for a putative CREB/ATF family transcription factor in the long-term cultured astrocytes and gliotic tissue. Molecular Brain Research. 69(1). 93–103. 93 indexed citations
19.
Tanno, Yoshihiro, Tetsuji Mori, Sachihiko Yokoya, et al.. (1999). Localization of huntingtin-interacting protein-2 (Hip-2) mRNA in the developing mouse brain. Journal of Chemical Neuroanatomy. 17(2). 99–107. 9 indexed citations
20.
Wakai, Kenji, Taro Nakajima, Kenya Kanazawa, et al.. (1995). Epidemiological Study of Tsutsugamushi Disease in Gunma Prefecture A Special Field Study and Serotype. Kansenshogaku zasshi. 69(10). 1118–1125. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026